Back to Search Start Over

Editorial: CD4+ T Cells in Cancer Immunotherapies.

Authors :
González-Navajas, José M.
Elkord, Eyad
Lee, Jongdae
Source :
Frontiers in Immunology; 9/6/2021, Vol. 12, p1-2, 2p
Publication Year :
2021

Abstract

Among the different immunotherapy approaches, immune checkpoint inhibition (ICI) therapy and chimeric antigen receptor (CAR) T cells have arguably shown the greatest potential. Keywords: CD4; immunotherapy; immune checkpoint inhibitor (ICI); cancer; T lymphocyte EN CD4 immunotherapy immune checkpoint inhibitor (ICI) cancer T lymphocyte 1 2 2 09/08/21 20210906 NES 210906 In the last 20 years, remarkable advances in the field of immunotherapy have led to new therapeutic options for patients with a wide range of cancer types. [Extracted from the article]

Details

Language :
English
ISSN :
16643224
Volume :
12
Database :
Complementary Index
Journal :
Frontiers in Immunology
Publication Type :
Academic Journal
Accession number :
152294829
Full Text :
https://doi.org/10.3389/fimmu.2021.737615